Background: Pulmonary hypertension (PH) occurring secondary to bronchopulmonary dysplasia (BPD) contributes to significant morbidity and mortality among extremely preterm infants and currently there are no effective and safe interventions. We have previously shown that prophylactic treatment with interleukin-1 receptor antagonist (IL-1Ra) prevents murine BPD, so we sought to determine if its protection also extends to murine BPD-PH.
Discovery Institute and Department of Physiology, Monash University, Melbourne, Australia Email: christine.bui@monash.edu
Background: Pulmonary hypertension (PH) occurring secondary to bronchopulmonary dysplasia (BPD) contributes to significant morbidity and mortality among extremely preterm infants and currently there are no effective and safe interventions. We have previously shown that prophylactic treatment with interleukin-1 receptor antagonist (IL-1Ra) prevents murine BPD, so we sought to determine if its protection also extends to murine BPD-PH.
Methods: Pregnant C57BL/6J mice received an i.p. injection of LPS (150 ug/kg) at d14 of gestation. Immediately after birth, pups were randomised to hyperoxia (65% O 2 ) or room air (21% O 2 ). Pups were treated with daily s.c. injections of IL-1Ra (10 mg/kg) or saline. On d28, lung parenchyma was assessed by histology, pulmonary blood vessels by synchrotron micro-CT imaging and pulmonary blood pressures by echocardiography. To assess pulmonary vasculature later in life, mice were returned to room air after d28 and then at d60 in vivo synchrotron radiation microangiography was performed.
Results: IL-1Ra prevented BPD-like lung disease (28% reduction in alveolar size, 34% increase in alveolar number compared to hyperoxia saline). Micro-CT revealed significant pulmonary vascular remodelling in hyperoxia saline-treated pups e.g. 41% decrease in small vessels (4-5μm diameter) and 35-fold increase in large vessels (50-60μm diameter), which was accompanied by PH (TPV/RVET 0.27 for hyperoxia saline vs 0.32 for controls); treatment with IL-1Ra was protective. In vivo microangiography revealed 18-25% fewer vessels across all branching generations in hyperoxia saline mice than air controls, which was rescued by IL-1Ra.
Conclusion: IL-1Ra protected the pulmonary vasculature of pups from perinatal inflammation and hyperoxia. Background: Preterm birth may increase the risk of anxiety and depression, but the stability of anxiety and depression from adolescence to adulthood is not well understood. This study aimed to determine (1) the prevalence of "at least mild" anxiety and depression symptoms in young adults born extremely preterm/extremely low birthweight (<28 weeks/ <1000 g; EP/ELBW) and with normal birthweight (>=2500 g; NBW); (2) the persistence of such increases in mental health symptoms identified in late adolescence and whether this varied by birth group.
YOUNG ADULT MENTAL HEALTH AFTER EXTREMELY PRETERM BIRTH IN THE EARLY 1990S
Methods: 170 EP/ELBW and 139 NBW 25 year-olds rated their current symptoms of depression and anxiety using the Center for Epidemiologic Studies Depression Scale-Revised and the Beck Anxiety Inventory. The prevalence of "at least mild" symptoms was analysed using logistic regression.
Results: Rates of "at least mild" current depression symptoms were similar between groups (29% EP/ELBW, 24% NBW, P = 0.39). Having at least mild depression scores on the same measure in adolescence was strongly associated with at least mild scores at 25 years (OR = 8.5, 95%CI = 4.3, 16.5; P < 0.001) and this did not vary according to birth group (interaction P = 0.39). Rates of current anxiety symptoms were also similar between groups (45% EP/ELBW, 42% NBW, P = 0.57). Having at least mild anxiety symptoms in adolescence was strongly associated with anxiety symptoms at 25 years (OR = 3.9, 95%CI = 2.3, 6.8; P < 0.001) irrespective of group (interaction P = 0.23).
Conclusions: Depression and anxiety symptoms occurred frequently in both EP/ELBW and NBW young adults. EP/ELBW young people were not more vulnerable than their NBW peers. Background: High levels of stress and burnout have been identified amongst Junior Medical Officers (JMOs), and are associated with absenteeism, mental ill health, and even suicide. Perinatal health care is an area with significant risk of adverse clinical incidents, following which medical staff can become the 'second victim'. JMO wellbeing has been shown to be improved by access to debriefing following stressful or traumatic outcomes.
WE NEED TO TALK: DEBRIEFING JUNIOR MEDICAL OFFICERS FOLLOWING STRESSFUL CLINICAL INCIDENTS
Methods: Opinions of Obstetric and Paediatric JMOs regarding the perceived need for stressful incident debriefing in a large (6000 delivery) tertiary unit were sought. Data was collected
